Showing 9361-9370 of 18562 results for "".
- Fostering Inclusivity: Transcatheter Tricuspid Valve Replacement Outcomes and Their Impact on Cardiac Trialshttps://reachmd.com/news/fostering-inclusivity-transcatheter-tricuspid-valve-replacement-outcomes-and-their-impact-on-cardiac-trials/2483111/The evolution of transcatheter tricuspid valve replacement (TTVR) is reshaping care pathways and spotlighting inclusivity in cardiac trials, with growing adoption bringing diversity questions to the fore. Procedural innovations that may speed recovery could also enable more inclusive
- Enhancing Surgical Outcomes: The Role of Robotic and Minimally Invasive Techniqueshttps://reachmd.com/news/enhancing-surgical-outcomes-the-role-of-robotic-and-minimally-invasive-techniques/2483112/Robotic and other minimally invasive techniques are reshaping surgical care in real time, as teams balance the promise of greater precision and shorter recovery against questions of access and long-term equivalence across specialties. The robotic precision allows more intricate surge
- Integrated Molecular and Clinical Approaches to Pulmonary Large Cell Neuroendocrine Carcinomahttps://reachmd.com/news/integrated-molecular-and-clinical-approaches-to-pulmonary-large-cell-neuroendocrine-carcinoma/2483105/Large cell neuroendocrine carcinoma (LCNEC) of the lung is an aggressive tumor with substantial molecular heterogeneity. The clinical challenge is integrating evolving genomic insights with pragmatic treatment pathways to inform care today while building evidence for tomorrow. Agains
- Revolutionizing Plaque Psoriasis Treatment: The Role of TYK2 Inhibitorshttps://reachmd.com/news/revolutionizing-plaque-psoriasis-treatment-the-role-of-tyk2-inhibitors/2483104/Patients dealing with moderate-to-severe plaque psoriasis often find themselves at a crossroads, struggling with limited treatment options that balance efficacy and safety. While multiple guideline-endorsed biologics and oral systemics are available, TYK2 inhibition offers an additio
- Harnessing Cross-Protection and AI: New Frontiers in Viral Infection Managementhttps://reachmd.com/news/harnessing-cross-protection-and-ai-new-frontiers-in-viral-infection-management/2483107/Emerging evidence is suggesting viral interference between common respiratory pathogens while clinical significance and durability are remaining uncertain, placing clinicians between acknowledging possible short‑lived protection and avoiding overinterpretation of early signals.
- Synchronizing Metabolism: Gene-Diet Interactions and Circadian Rhythmshttps://reachmd.com/news/synchronizing-metabolism-gene-diet-interactions-and-circadian-rhythms/2483116/Clinicians are weighing how gene–diet interactions and circadian timing are reshaping metabolic care, even as the evidence is still emerging. The practical question is how to align meal timing and genetics-aware nutrition with patients’ daily rhythms without overpromising benefits. T
- Innovative IBD Management: Preventing Clots and Enhancing Gut Healthhttps://reachmd.com/news/innovative-ibd-management-preventing-clots-and-enhancing-gut-health/2483117/Clinicians are navigating the multifaceted management of inflammatory bowel disease (IBD), where the challenge of preventing blood clots intersects with a growing interest in microbiome-informed strategies to modulate inflammation. Because patients with IBD often face heightened clot
- JAK Inhibitors Linked to Lower Adjunctive Therapy Use Than Dupilumab in ADhttps://reachmd.com/news/jak-inhibitors-linked-to-lower-adjunctive-therapy-use-than-dupilumab-in-ad/2483122/Patients with atopic dermatitis (AD) treated with oral Janus kinase (JAK) inhibitors used fewer adjunctive therapies over the long term compared to those receiving dupilumab, according to a retrospective study published ahead of print in
- Safeguarding Vision: Integrating Eye Safety in Pediatric Care and Schoolshttps://reachmd.com/news/safeguarding-vision-integrating-eye-safety-in-pediatric-care-and-schools/2483081/Children’s eye health is increasingly relying on coordinated action between healthcare and schools—yet while risks from sports and UV are rising, adoption of proven protections is lagging. Sports are a leading source of pediatric eye injuries—particularly during scho
- Innovative Therapeutics in Pulmonology: Meeting Unmet Needshttps://reachmd.com/news/innovative-therapeutics-in-pulmonology-meeting-unmet-needs/2483090/In a field where innovation seeks to meet persistent needs, two therapies are drawing attention. Brensocatib and mepolizumab are emerging options in non-CF bronchiectasis and eosinophilic COPD, respectively, with benefits and risks still being defined through ongoing studies and careful pat